Updated:
VitaLink Research
VitaLink Research facilitates connections between physicians, medical professionals, and site staff to conduct clinical trials. The company was acquired by...
VitaLink Research
VitaLink Research facilitates connections between physicians, medical professionals, and site staff to conduct clinical trials. The company was acquired by Velocity Clinical Research on September 23rd, 2021.
General information
Firm type
Dedicated Clinical Research Site Network
Year founded
2004
Location
Region
North America
Country
United States
City
Greenville
Corporate office
Greenville, SC, United States
Frequently asked questions
Who owns or controls VitaLink Research?
VitaLink Research's ownership is not publicly disclosed. The firm is structured as a clinical trial site network, but no information on its principals or ownership group is available from public sources. This limits external visibility into its governance and strategic direction.
What types of clinical trials does VitaLink Research conduct?
VitaLink Research conducts Phase I through Phase IV clinical trials, covering early-stage safety studies through post-market surveillance. The firm focuses on therapeutic areas including central nervous system disorders, cardiovascular disease, and metabolic conditions, based on publicly documented trial work with sponsors such as Eli Lilly and Pfizer.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: